Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2019 | 04-2019 | 01-2019 | 10-2018 | 07-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 342 | 459 | 905 | 1,352 | 1,686 |
| Marketable Securities | 758 | 756 | 755 | 780 | 1,227 |
| Receivables | 213 | 614 | 389 | 367 | 308 |
| TOTAL | $1,330 | $1,866 | $2,105 | $2,577 | $3,231 |
| Non-Current Assets | |||||
| PPE Net | 200 | 211 | 223 | 225 | 234 |
| TOTAL | $200 | $211 | $223 | $225 | $234 |
| Total Assets | $1,530 | $2,076 | $2,327 | $2,802 | $3,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 211 | 428 | 251 | 265 | 375 |
| TOTAL | $211 | $428 | $251 | $265 | $375 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $211 | $428 | $251 | $265 | $375 |
| Shareholders' Equity | |||||
| Common Shares | 27,921 | 27,536 | 27,550 | 26,337 | 25,984 |
| Retained earnings | -30,641 | -29,887 | -29,442 | -29,911 | -28,871 |
| Other shareholders' equity | 791 | 789 | 789 | 2,787 | 2,756 |
| TOTAL | $1,319 | $1,648 | $2,077 | $2,536 | $3,089 |
| Total Liabilities And Equity | $1,530 | $2,076 | $2,327 | $2,802 | $3,464 |